{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:45:56Z","timestamp":1778885156218,"version":"3.51.4"},"reference-count":61,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Niemann-Pick disease type C1 (NP-C1) is a rare lysosomal storage disorder resulting from mutations in an endolysosomal cholesterol transporter, NPC1. Despite typically presenting with pronounced neurological manifestations, NP-C1 also resembles long-term congenital immunodeficiencies that arise from impairment of cytotoxic T lymphocyte (CTL) effector function. CTLs kill their targets through exocytosis of the contents of lysosome-like secretory cytotoxic granules (CGs) that store and ultimately release the essential pore-forming protein perforin and proapoptotic serine proteases, granzymes, into the synapse formed between the CTL and target cell. We discovered that NPC1 deficiency increases CG lipid burden, impairs autophagic flux through stalled trafficking of the transcription factor EB (TFEB), and dramatically reduces CTL cytotoxicity. Using a variety of immunological and cell biological techniques, we found that the cytotoxic defect arises specifically from impaired perforin pore formation. We demonstrated defects of CTL function of varying severity in patients with NP-C1, with the greatest losses of function associated with the most florid and\/or earliest disease presentations. Remarkably, perforin function and CTL cytotoxicity were restored in\u00a0vitro by promoting lipid clearance with therapeutic 2-hydroxypropyl-\u03b2-cyclodextrin; however, restoration of autophagy through TFEB overexpression was ineffective. Overall, our study revealed that NPC1 deficiency has a deleterious impact on CTL (but not natural killer cell) cytotoxicity that, in the long term, may predispose patients with NP-C1 to atypical infections and impaired immune surveillance more generally.<\/jats:p>","DOI":"10.1182\/blood.2021013477","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T19:55:00Z","timestamp":1643226900000},"page":"1833-1849","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1"],"prefix":"10.1182","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1254-4200","authenticated-orcid":false,"given":"Daniela","family":"Castiblanco","sequence":"first","affiliation":[{"name":"Killer Cell Biology Laboratory and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3033-2642","authenticated-orcid":false,"given":"Jesse A.","family":"Rudd-Schmidt","sequence":"additional","affiliation":[{"name":"Killer Cell Biology Laboratory and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahereh","family":"Noori","sequence":"additional","affiliation":[{"name":"Killer Cell Biology Laboratory and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien R.","family":"Sutton","sequence":"additional","affiliation":[{"name":"Cancer Cell Death Laboratory, Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5440-2764","authenticated-orcid":false,"given":"Ya Hui","family":"Hung","sequence":"additional","affiliation":[{"name":"Oxidation Biology Unit, Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health and University of Melbourne, Parkville, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thijs W. H.","family":"Flinsenberg","sequence":"additional","affiliation":[{"name":"Killer Cell Biology Laboratory and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0282-1200","authenticated-orcid":false,"given":"Adrian W.","family":"Hodel","sequence":"additional","affiliation":[{"name":"Killer Cell Biology Laboratory and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8756-229X","authenticated-orcid":false,"given":"Neil D.","family":"Young","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Parkville, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2409-9239","authenticated-orcid":false,"given":"Nicholas","family":"Smith","sequence":"additional","affiliation":[{"name":"Neurology and Clinical Neurophysiology, Women\u2019s and Children\u2019s Hospital, North Adelaide, Australia;"},{"name":"Paediatric Neurodegenerative Disease Research Group, Discipline of Paediatrics, University of Adelaide, Adelaide, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drago","family":"Bratkovic","sequence":"additional","affiliation":[{"name":"Metabolic Clinic, Women\u2019s and Children\u2019s Hospital, North Adelaide, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Peters","sequence":"additional","affiliation":[{"name":"Metabolic Medicine, Royal Children\u2019s Hospital, Parkville, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1389-3691","authenticated-orcid":false,"given":"Mark","family":"Walterfang","sequence":"additional","affiliation":[{"name":"Oxidation Biology Unit, Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health and University of Melbourne, Parkville, Australia;"},{"name":"Neuropsychiatry Unit, Royal Melbourne Hospital, Melbourne, Australia; and"},{"name":"Melbourne Neuropsychiatry Centre and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0983-1532","authenticated-orcid":false,"given":"Joseph A.","family":"Trapani","sequence":"additional","affiliation":[{"name":"Cancer Cell Death Laboratory, Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia;"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia J.","family":"Brennan","sequence":"additional","affiliation":[{"name":"Killer Cell Biology Laboratory and"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6410-009X","authenticated-orcid":false,"given":"Ilia","family":"Voskoboinik","sequence":"additional","affiliation":[{"name":"Killer Cell Biology Laboratory and"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"5","key":"2022032421390217600_B1","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1074\/jbc.TM118.004165","article-title":"NPC intracellular cholesterol transporter 1 (NPC1)-mediated cholesterol export from lysosomes","volume":"294","author":"Pfeffer","year":"2019","journal-title":"J Biol Chem."},{"issue":"4","key":"2022032421390217600_B2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1194\/jlr.M013789","article-title":"Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations","volume":"52","author":"Ramirez","year":"2011","journal-title":"J Lipid Res."},{"key":"2022032421390217600_B3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J Rare Dis."},{"issue":"11","key":"2022032421390217600_B4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/ajmg.a.31735","article-title":"The National Niemann-Pick C1 disease database: report of clinical features and health problems","volume":"143A","author":"Garver","year":"2007","journal-title":"Am J Med Genet A."},{"issue":"18","key":"2022032421390217600_B5","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.3390\/ijms20184392","article-title":"Current challenges in understanding the cellular and molecular mechanisms in Niemann-Pick disease type C1","volume":"20","author":"Br\u00e4uer","year":"2019","journal-title":"Int J Mol Sci."},{"issue":"3","key":"2022032421390217600_B6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/jcm9030679","article-title":"Molecular genetics of Niemann-Pick type C disease in Italy: an update on 105 patients and description of 18 NPC1 novel variants","volume":"9","author":"Dardis","year":"2020","journal-title":"J Clin Med."},{"issue":"1","key":"2022032421390217600_B7","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1038\/s41598-019-41707-y","article-title":"Different Niemann-Pick C1 genotypes generate protein phenotypes that vary in their intracellular processing, trafficking and localization","volume":"9","author":"Shammas","year":"2019","journal-title":"Sci Rep."},{"issue":"6","key":"2022032421390217600_B8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jnc.14895","article-title":"Niemann-Pick type C disease: cellular pathology and pharmacotherapy","volume":"153","author":"Wheeler","year":"2020","journal-title":"J Neurochem."},{"issue":"12","key":"2022032421390217600_B9","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/hmg\/ddm100","article-title":"Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects","volume":"16","author":"Pacheco","year":"2007","journal-title":"Hum Mol Genet."},{"issue":"5","key":"2022032421390217600_B10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.celrep.2013.10.042","article-title":"Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease","volume":"5","author":"Sarkar","year":"2013","journal-title":"Cell Rep."},{"issue":"6","key":"2022032421390217600_B11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4161\/auto.28623","article-title":"Restarting stalled autophagy a potential therapeutic approach for the lipid storage disorder, Niemann-Pick type C1 disease","volume":"10","author":"Sarkar","year":"2014","journal-title":"Autophagy."},{"issue":"4","key":"2022032421390217600_B12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s10620-018-4914-x","article-title":"Gastrointestinal tract pathology in a BALB\/c Niemann-Pick disease type C1 null mouse model","volume":"63","author":"Cougnoux","year":"2018","journal-title":"Dig Dis Sci."},{"issue":"2","key":"2022032421390217600_B13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.gene.2015.12.033","article-title":"Extensive macrophage accumulation in young and old Niemann-Pick C1 model mice involves the alternative, M2, activation pathway and inhibition of macrophage apoptosis","volume":"578","author":"Deutsch","year":"2016","journal-title":"Gene."},{"issue":"6","key":"2022032421390217600_B14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/gutjnl-2015-310382","article-title":"Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn\u2019s disease","volume":"66","author":"Schwerd","year":"2017","journal-title":"Gut."},{"issue":"1","key":"2022032421390217600_B15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood-2013-03-488692","article-title":"Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1","volume":"123","author":"Speak","year":"2014","journal-title":"Blood."},{"issue":"6","key":"2022032421390217600_B16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nri819","article-title":"Cytotoxic T lymphocytes: all roads lead to death","volume":"2","author":"Barry","year":"2002","journal-title":"Nat Rev Immunol."},{"key":"2022032421390217600_B17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fimmu.2013.00441","article-title":"Perforinopathy: a spectrum of human immune disease caused by defective perforin delivery or function","volume":"4","author":"Voskoboinik","year":"2013","journal-title":"Front Immunol."},{"issue":"5","key":"2022032421390217600_B18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjh.12293","article-title":"Advances in understanding the pathogenesis of HLH","volume":"161","author":"Usmani","year":"2013","journal-title":"Br J Haematol."},{"issue":"8","key":"2022032421390217600_B19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nri2803","article-title":"Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules","volume":"10","author":"de Saint Basile","year":"2010","journal-title":"Nat Rev Immunol."},{"issue":"5","key":"2022032421390217600_B20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nnano.2016.303","article-title":"Real-time visualization of perforin nanopore assembly","volume":"12","author":"Leung","year":"2017","journal-title":"Nat Nanotechnol."},{"issue":"14","key":"2022032421390217600_B21","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2012-07-446146","article-title":"Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack","volume":"121","author":"Lopez","year":"2013","journal-title":"Blood."},{"issue":"6493","key":"2022032421390217600_B22","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1126\/science.aay9207","article-title":"Supramolecular attack particles are autonomous killing entities released from cytotoxic T cells","volume":"368","author":"B\u00e1lint","year":"2020","journal-title":"Science."},{"issue":"6","key":"2022032421390217600_B23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat Rev Immunol."},{"issue":"5323","key":"2022032421390217600_B24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.277.5323.232","article-title":"Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene","volume":"277","author":"Loftus","year":"1997","journal-title":"Science."},{"issue":"1","key":"2022032421390217600_B25","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1038\/s41467-019-13385-x","article-title":"Lipid order and charge protect killer T cells from accidental death","volume":"10","author":"Rudd-Schmidt","year":"2019","journal-title":"Nat Commun."},{"issue":"8","key":"2022032421390217600_B26","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.4049\/jimmunol.1901396","article-title":"Efficient CRISPR\/Cas9 gene editing in uncultured naive mouse T cells for in\u00a0vivo studies","volume":"204","author":"N\u00fcssing","year":"2020","journal-title":"J Immunol."},{"issue":"6","key":"2022032421390217600_B27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood-2017-08-803668","article-title":"Adaptive reprogramming of NK cells in X-linked lymphoproliferative syndrome","volume":"131","author":"Opat","year":"2018","journal-title":"Blood."},{"issue":"3","key":"2022032421390217600_B28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2818.1993.tb03313.x","article-title":"Measurement of co-localization of objects in dual-colour confocal images","volume":"169","author":"Manders","year":"1993","journal-title":"J Microsc."},{"issue":"7","key":"2022032421390217600_B29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods."},{"issue":"5","key":"2022032421390217600_B30","first-page":"1071","article-title":"T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors","volume":"59","author":"Marzo","year":"1999","journal-title":"Cancer Res."},{"key":"2022032421390217600_B31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/bs.mie.2017.11.033","article-title":"Quantitative methods to investigate the 4D dynamics of heterochromatic repair sites in Drosophila cells","volume":"601","author":"Caridi","year":"2018","journal-title":"Methods Enzymol."},{"issue":"23","key":"2022032421390217600_B32","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1016\/j.febslet.2006.06.008","article-title":"Lipid imbalance in the neurological disorder, Niemann-Pick C disease","volume":"580","author":"Vance","year":"2006","journal-title":"FEBS Lett."},{"issue":"1","key":"2022032421390217600_B33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12944-019-1088-2","article-title":"A therapy with miglustat, 2-hydroxypropyl-\u03b2-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1","volume":"18","author":"Ne\u00dflauer","year":"2019","journal-title":"Lipids Health Dis."},{"issue":"5","key":"2022032421390217600_B34","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/febs.13649","article-title":"Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity","volume":"283","author":"Sutton","year":"2016","journal-title":"FEBS J."},{"issue":"5","key":"2022032421390217600_B35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/jnc.14564","article-title":"Lysosome biogenesis in health and disease","volume":"148","author":"Bajaj","year":"2019","journal-title":"J Neurochem."},{"issue":"19","key":"2022032421390217600_B36","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"Palmieri","year":"2011","journal-title":"Hum Mol Genet."},{"issue":"6036","key":"2022032421390217600_B37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science."},{"issue":"1","key":"2022032421390217600_B38","doi-asserted-by":"crossref","first-page":"8663","DOI":"10.1038\/s41598-020-65627-4","article-title":"2-Hydroxypropyl-gamma-cyclodextrin overcomes NPC1 deficiency by enhancing lysosome-ER association and autophagy","volume":"10","author":"Singhal","year":"2020","journal-title":"Sci Rep."},{"issue":"10104","key":"2022032421390217600_B39","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet."},{"issue":"10","key":"2022032421390217600_B40","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41419-018-1056-1","article-title":"Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1","volume":"9","author":"Singhal","year":"2018","journal-title":"Cell Death Dis."},{"issue":"11","key":"2022032421390217600_B41","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.4049\/jimmunol.1402207","article-title":"A method for detecting intracellular perforin in mouse lymphocytes","volume":"193","author":"Brennan","year":"2014","journal-title":"J Immunol."},{"issue":"10","key":"2022032421390217600_B42","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.15252\/embr.201744351","article-title":"Regulation of perforin activation and pre-synaptic toxicity through C-terminal glycosylation","volume":"18","author":"House","year":"2017","journal-title":"EMBO Rep."},{"issue":"1","key":"2022032421390217600_B43","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1038\/s41467-019-12301-7","article-title":"The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications","volume":"10","author":"G\u00f6tzke","year":"2019","journal-title":"Nat Commun."},{"issue":"7322","key":"2022032421390217600_B44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature09518","article-title":"The structural basis for membrane binding and pore formation by lymphocyte perforin","volume":"468","author":"Law","year":"2010","journal-title":"Nature."},{"issue":"6","key":"2022032421390217600_B45","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/320606","article-title":"Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop","volume":"68","author":"Millat","year":"2001","journal-title":"Am J Hum Genet."},{"issue":"4","key":"2022032421390217600_B46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0925-4439(91)90069-L","article-title":"Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing","volume":"1096","author":"Vanier","year":"1991","journal-title":"Biochim Biophys Acta."},{"issue":"23","key":"2022032421390217600_B47","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1021\/jm401604x","article-title":"Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforin","volume":"56","author":"Spicer","year":"2013","journal-title":"J Med Chem."},{"issue":"9","key":"2022032421390217600_B48","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1074\/jbc.M413303200","article-title":"Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: a critical role for aspartate residues 429, 435, 483, and 485 but not 491","volume":"280","author":"Voskoboinik","year":"2005","journal-title":"J Biol Chem."},{"issue":"11","key":"2022032421390217600_B49","doi-asserted-by":"crossref","first-page":"101691","DOI":"10.1016\/j.isci.2020.101691","article-title":"c-Abl inhibition activates TFEB and promotes cellular clearance in a lysosomal disorder","volume":"23","author":"Contreras","year":"2020","journal-title":"iScience."},{"key":"2022032421390217600_B50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcell.2019.00114","article-title":"Transcriptional regulation of autophagy: mechanisms and diseases","volume":"7","author":"Di Malta","year":"2019","journal-title":"Front Cell Dev Biol."},{"issue":"5","key":"2022032421390217600_B51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/emmm.201202176","article-title":"Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease","volume":"5","author":"Spampanato","year":"2013","journal-title":"EMBO Mol Med."},{"issue":"8","key":"2022032421390217600_B52","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2017.1329081","article-title":"Methyl-\u03b2-cyclodextrin restores impaired autophagy flux in Niemann-Pick C1-deficient cells through activation of AMPK","volume":"13","author":"Dai","year":"2017","journal-title":"Autophagy."},{"issue":"8","key":"2022032421390217600_B53","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/eji.200939435","article-title":"Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity?","volume":"39","author":"Sun","year":"2009","journal-title":"Eur J Immunol."},{"issue":"5446","key":"2022032421390217600_B54","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science."},{"issue":"9","key":"2022032421390217600_B55","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood-2014-09-602946","article-title":"A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice","volume":"125","author":"Sepulveda","year":"2015","journal-title":"Blood."},{"issue":"11","key":"2022032421390217600_B56","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2004-04-1477","article-title":"A proportion of patients with lymphoma may harbor mutations of the perforin gene","volume":"105","author":"Clementi","year":"2005","journal-title":"Blood."},{"key":"2022032421390217600_B57","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3389\/fimmu.2017.00944","article-title":"Late-onset non-HLH presentations of growth arrest, inflammatory arachnoiditis, and severe infectious mononucleosis, in siblings with hypomorphic defects in UNC13D.","volume":"8","author":"Gray","year":"2017","journal-title":"Front Immunol."},{"issue":"12","key":"2022032421390217600_B58","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1002\/ajmg.a.61880","article-title":"Consequences of treatment for hemophagocytic lymphohistiocytosis in a patient with undiagnosed Gaucher disease type 1","volume":"182","author":"Anderson","year":"2020","journal-title":"Am J Med Genet A."},{"key":"2022032421390217600_B59","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.ymgmr.2020.100663","article-title":"Diffuse large B-cell non-Hodgkin\u2019s lymphoma in Gaucher disease","volume":"25","author":"Bonesteele","year":"2020","journal-title":"Mol Genet Metab Rep."},{"issue":"1","key":"2022032421390217600_B60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/17474086.2016.1112732","article-title":"Hematological manifestations and complications of Gaucher disease","volume":"9","author":"Linari","year":"2016","journal-title":"Expert Rev Hematol."},{"issue":"1","key":"2022032421390217600_B61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/path.4452","article-title":"Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy","volume":"235","author":"Pavlova","year":"2015","journal-title":"J Pathol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/12\/1833\/1882256\/bloodbld2021013477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/12\/1833\/1882256\/bloodbld2021013477.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:44:51Z","timestamp":1648158291000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/12\/1833\/483699\/Severely-impaired-CTL-killing-is-a-feature-of-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,3,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021013477","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]}}}